» Articles » PMID: 26846279

A Novel Dermal Matrix Generated from Burned Skin As a Promising Substitute for Deep-degree Burns Therapy

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2016 Feb 6
PMID 26846279
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The extensive skin defects induced by severe burns are dangerous and can be fatal. Currently, the most common therapy is tangential excision to remove the necrotic or denatured areas of skin, followed by skin grafting. Xenogeneic dermal substitutes, such as porcine acellular dermal matrix (ADM), are typically used to cover the burn wounds, and may accelerate wound healing. It is assumed that burned skin that still maintains partial biological activity may be recycled to construct an autologous acellular dermal matrix, termed 'deep‑degree burned dermal matrix (DDBDM)'. In theory, DDBDM may avoid the histoincompatibility issues associated with foreign or xenogeneic dermal matrices, and reduce therapy costs by making full use of discarded skin. In the present study, the collagens within prepared DDBDM were thickened, disorganized and partially fractured, however, they still maintained their reticular structure and tensile strength (P<0.01). Through microarray analysis of the cytokines present in ADM and DDBDM, it was determined that the DDBDM did not produce excessive levels of harmful burn toxins. Following 4 weeks of subcutaneous implantation, ADM and DDBDM were incompletely degraded and maintained good integrity. No significant inflammatory reaction or rejection were observed, which indicated that ADM and DDBDM have good histocompatibility. Therefore, DDBDM may be a useful material for the treatment of deep‑degree burns.

Citing Articles

Acellular dermal matrix in reconstructive surgery: Applications, benefits, and cost.

Mohammadyari F, Parvin S, Khorvash M, Amini A, Behzadi A, HajEbrahimi R Front Transplant. 2024; 2:1133806.

PMID: 38993878 PMC: 11235262. DOI: 10.3389/frtra.2023.1133806.


Clinical applications of acellular dermal matrices: A review.

Petrie K, Cox C, Becker B, Mackay B Scars Burn Heal. 2022; 8:20595131211038313.

PMID: 35083065 PMC: 8785275. DOI: 10.1177/20595131211038313.


Effect of TNF-α Concentration on Selected Clinical Parameters of Swine After Burns.

Aleksiewicz R, Lutnicki K, Likus M, Gatkiewicz L J Vet Res. 2018; 62(3):335-340.

PMID: 30584613 PMC: 6296001. DOI: 10.2478/jvetres-2018-0047.


Clinical study on local application of low-dose insulin for promoting wound healing after operation for deep burns.

Zeng M, Zhi Y, Liu W, Zhang W, Xu J Exp Ther Med. 2016; 12(5):3221-3226.

PMID: 27882141 PMC: 5103771. DOI: 10.3892/etm.2016.3749.

References
1.
Pierce M, Sheridan R, Park B, Cense B, de Boer J . Collagen denaturation can be quantified in burned human skin using polarization-sensitive optical coherence tomography. Burns. 2004; 30(6):511-7. DOI: 10.1016/j.burns.2004.02.004. View

2.
Kagan R, Peck M, Ahrenholz D, Hickerson W, Holmes 4th J, Korentager R . Surgical management of the burn wound and use of skin substitutes: an expert panel white paper. J Burn Care Res. 2013; 34(2):e60-79. DOI: 10.1097/BCR.0b013e31827039a6. View

3.
Constantian M . Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients. Ann Surg. 1978; 188(2):209-15. PMC: 1396754. DOI: 10.1097/00000658-197808000-00014. View

4.
Allman A, McPherson T, Badylak S, Merrill L, Kallakury B, Sheehan C . Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response. Transplantation. 2001; 71(11):1631-40. DOI: 10.1097/00007890-200106150-00024. View

5.
Eldad A, Din A, Weinberg A, Neuman A, LIPTON H, Ben-Bassat H . Cryopreserved cadaveric allografts for treatment of unexcised partial thickness flame burns: clinical experience with 12 patients. Burns. 1998; 23(7-8):608-14. DOI: 10.1016/s0305-4179(97)00054-5. View